Build your professional network on facebook via our app Go to app
 
 
Industry : Biotechnology Functional Area : R&D
Activity:  0 comments  199 views  last activity : 07 06 2010 20:18:04 +0000
 Refer 10
Share
 
 
 

Since the introduction of generic drugs in Brazil five years ago, the country's pharmaceutical industry has undergone a transformation. Generic drugs have been steadily gaining market share and today represent 11.6% of total production. Their rise has led to a decline in the influence of major multinational drug companies that sell branded products in the domestic market.

Generic drugs, however, are not the only danger confronting these multinationals. In an attempt to negotiate discounted prices, the Brazilian government is threatening to violate the patents on medications used to treat AIDS.

 That threat alone, say the multinationals, will lead big drug companies to reduce their investments in Brazil's pharmaceutical sector.

 

Because of the continued danger that patents will be violated, employment in Brazil's scientific research sector has dropped to about 20,000 from a total of 24,000 jobs in 1999

 
TrackBack URL:
0 comments on "Generic Drugs in Brazil Are a Hard Pill for Big Pharma to Swallow"
Add your comment on "Generic Drugs in Brazil Are a Hard Pill for Big Pharma to Swallow"

Rate:
Submit
Leading Recruitment Firm
Leading Recruitment Firm
Viewers also viewed
A new proposal is being made from India's drug regulator where the ads of morning after pills...
 
218 referals 75 arguments, 3522 views
Delhi Police made one of its biggest drug hauls in recent years while probing the nexus between...
 
416 referals 6 arguments, 280 views
Yes vs No
 
378 referals 41 arguments, 1415 views
more...  
Recent Knowledge (64)
World IP Day, 26 April: "The Power of Ideas as the seedbed for innovation and creativity" "World...
4 referals 1 comments, 217 views
My friend Rizwan Khan mailed me this interesting draft made by a Pakis journalist.   Written by...
 
427 referals 42 comments, 2675 views
NANDKUMAR B.SAWANT.,M.COM.LL.B.(MUMBAI),ADVOCATE MOBILE.09325226691, 09271971251...
 
24 referals 17 comments, 11573 views
more...  
More From Author
Kaushik is right, research is a field where most of the inventions receive recognition after the person responsiblefor it is dead, This because of the failure rates, dealing with life science is not an easy job, every time you get the unexpected...
According to me there is a good news that the financial crisis does not have an incremental effect on overall industry productivity (biotech + pharma). As compared to the performance of the NASDAQ biotechnology index to the performance of NASDAQ...
yes Mr. karamjeet its very true that biotechnology will be the driving force behind the agriculture and the farmers of the country who are the backbone of the country, and biotechnology is seeing a upward movement lately, and in next decade it will...
more...